Delivery Order SPE2DE21D0017-SPE2D625F8RN5
Award Date 7/25/25
Potential Completion Date 8/15/25
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Lockhart, FL 32810, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on April 30, 2025, for BinaxNOW COVID-19 antigen cards. This fixed-price contract with economic price adjustment has an ultimate completion date of May 20, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating full and open competition. Funding originates from the Defense Logistics Agency's Medical Supply...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order valued at $6,030.30 for BinaxNOW COVID-19 antigen test cards on July 31, 2025, with an ultimate completion date of August 21, 2025. The contract, which carries a fixed-price structure with economic price adjustment provisions, was awarded without a set-aside designation, indicating full and open competition. Performance will be executed in Lockhart, Florida, and the contract is funded through...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 18, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,206.06. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lockhart, Florida. The contract represents an open competition award with no set-aside designation and is scheduled for ultimate completion on September...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on January 14, 2025, for BinaxNOW COVID-19 Antigen Cards. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and is scheduled for completion by February 5, 2025. The contract will be performed at Abbott's facility in Lockhart, Florida. No set-aside designation was applied to this award, indicating it...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award valued at $4,422.22 on July 30, 2025, for BinaxNOW COVID-19 antigen cards to be delivered to Lockhart, Florida. The contract employs a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order with economic price adjustment on August 20, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,005.05. The contract, issued without set-aside designation, represents an open competition award and is funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment and diagnostic...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 18, 2025, for COVID-19 test kits to support the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of September 29, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 23, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $21,106.05. This fixed-price contract with economic price adjustment was competitively awarded without set-aside designation and is funded by the Defense Logistics Agency (DLA) Medical Supply Chain. The ultimate completion date is May 14, 2025, and performance will take place in Lockhart, Florida. The...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $6,030.30 fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test cards. This contract does not have a set-aside designation. The award is part of Abbott's existing indefinite-delivery, indefinite-quantity (IDIQ) contracts with the Department of Veterans Affairs and Department of Defense to supply diagnostic testing products and...